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Abstract
Background: The ErbB receptor tyrosine kinases are major contributors to malignant transformation. These receptors are
frequently overexpressed in a variety of human carcinomas. The role of the ErbB receptors and their ligands in carcinomas
and the mechanism by which their overexpression leads to cancer development is still unclear. Ligand binding to specific
ErbB receptor is followed by receptor dimerization, phosphorylation and recruitment of SH2 containing cytoplasmic
proteins, which initiate the cascade of signaling events. Nevertheless, increasing data suggest that there are non-
phosphorylated receptor–substrate interactions that may affect ErbB-mediated responses.
Methodology/Principal Findings: In the present study, using GST-ErbB4 fusion protein pull down assay and mass
spectroscopic analysis, we have found the ErbB receptors interact with nucleolin via their cytoplasmic tail. Nucleolin is a
ubiquitous, nonhistone, nucleolar, multifunctional phosphoprotein that is also overexpressed in cancer cells. Our results
demonstrate that overexpression of ErbB1 and nucleolin may lead to receptor dimerization, phosphorylation and to
anchorage independent growth.
Conclusions/Significance: The oncogenic potential of ErbB depends on receptor levels and activation. Our results suggest
that nucleolin may affect ErbB dimerization and activation leading to enhanced cell growth.
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Introduction
The ErbB subfamily of receptor tyrosine kinase contains four
members: the epidermal growth factor (EGF) receptor (also called
ErbB-1) [1], Neu/HER-2/ErbB-2 [2–4], HER-3/ErbB-3 [5,6]
and HER-4/ErbB-4 [7]. These tyrosine kinase receptors possess a
large glycosylated extracellular domain to which the ligand binds,
a single hydrophobic transmembrane region and a cytoplasmic
domain, which carry the tyrosine kinase activity and regulatory
phosphorylation sites [8]. The ErbB receptors are expressed in
various tissues of epithelial, mesenchymal and neuronal origin.
Under normal physiological conditions, activation of the ErbB
receptors is controlled by the spatial and temporal expression of
their ligands, which are members of the EGF family of growth
factors [9]. Ligand binding to ErbB receptors induces the
formation of receptor homo- and heterodimers and activation of
the intrinsic kinase domain, resulting in phosphorylation on
specific tyrosine residues within the cytoplasmic tail. These
phosphorylated residues serve as docking sites for a range of
proteins, the recruitment of which leads to the activation of
intracellular signaling pathways [10].
Protein-protein interactions between domains and specific
peptide motifs are key principle of signaling events. Sequence
containing phosphotyrosine interacts with cognate SH2 or PTB
domains [11]. In addition, increasing data suggest that there are
non-phosphorylated receptor–substrate interactions. For instance,
eps8, a 92 kDa SH3 domain containing protein, has been
identified as a substrate for the EGFR based on its association
with the EGFR juxtamembrane domain after EGF stimulation
[12]. Furthermore, the association of a nuclear localizing zinc-
finger protein, ZPR1, with the cytoplasmic tyrosine kinase domain
of the EGFR, is decreased by EGF stimulation [13]. Another
example for receptor–substrate interaction was demonstrated for
Ebp1 association with the juxtamembrane domain of ErbB-3 in a
tyrosine kinase-independent manner. Ebp1 dissociates from ErbB-
3 after NRG activation and translocates to the nucleus [14]. It was
also demonstrated that Erbin PDZ domain binds to the c-terminal
end of ErbB2 receptor and regulates its activity [15]. Moreover, it
was also demonstrated that ErbB4 binds PDZ domain-containing
proteins that affect ErbB4 localization and signaling [16]. Using a
glutathione-S-transferase (GST) fusion protein with ErbB4 cyto-
plasmic tail and pull down assay we identified nucleolin as a new
protein that interacts with ErbB proteins.
Nucleolin is an abundantly expressed acidic phosphoprotein of
exponentially growing cells. It is involved in the control of
transcription of ribosomal RNA (rRNA) genes by RNA polymer-
ase I, in ribosome maturation and assembly, and in nucleocyto-
plasmic transportation of ribosomal components [17]. Nucleolin is
a ubiquitous, nonhistone nucleolar phosphoprotein, present in
abundance at the dense fibrillar and granular regions of nucleolus
[18,19]. Intact nucleolin is the major species and represents 5% of
nucleolar protein in dividing cells. In nondividing cells, degraded
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to autodegradation [20]. The protein would therefore appear to be
involved in fundamental aspects of transcriptional regulation, cell
proliferation, and growth. Recently it was demonstrated that
nucleolin, is a multifunctional shuttling protein present in nucleus,
cytoplasm, and on the surface of some types of cells [17]. In the
present study we demonstrate that ErbB proteins and nucleolin
interact. This interaction leads to receptor dimerization and
activation as well as to colonies growth on soft agar. We therefore
suggest that the cross talk between nucleolin and ErbB proteins
may be related to tumor growth.
Results
ErbB receptors interact with nucleolin
To identify new ErbB4 interacting proteins we used a pull down
assay. A chimeric fusion protein of GST and ErbB4 cytoplasmic tail
(GST-ErbB4)wasconstructed andusedasa baitto pulldownErbB4
binding proteins. Affinity chromatography of PC12 cell extracts on a
GST-ErbB4 affinity matrix revealed a major ErbB4-binding band at
a molecular mass of 110 kD (Figure 1A). Mass spectrometry analysis
indicated thatthe 110-kD band is nucleolin.The identification of the
110-kD protein as nucleolin was confirmed by immunoblotting.
First, cell extracts were prepared from COS7 cells transfected with
the expression vector encoding Myc-Nucleolin. Lysates were mixed
with the GST-ErbB4 beads or with GST beads as a control. A
monoclonal anti-Myc antibody, revealed a major 110-kD band in
the GST-ErbB4-bound material (Figure 1B). This band was not
present in eluates from the control GST matrix. Second, the
interaction was assayed on endogenous nucleolin in cell extracts
prepared from DU145 prostate cancer cells. As shown in Figure 1C,
GST-ErbB4 but not GST pulled down endogenous nucleolin. To
further substantiate the results we also performed co-immunopre-
cipitation experiments. Myc-tagged nucleolin was coexpressed with
ErbB4 expression vector. Cell extracts were precipitated with anti-
Myc monoclonal antibodies and blotted with anti-ErbB4 polyclonal
antibodies (Figure 2A). As shown, nucleolin co-immunoprecipitated
ErbB4 protein. As a control we used Myc-TGFbIIR, which did not
precipitated ErbB4. Taken together, these results show that the
cytoplasmic tail of ErbB4 can specifically interact with nucleolin.
Four structurally and functionally distinct ErbB4 isoforms been
identified. One pair of isoforms differs within their extracellular
juxtamembrane domains (JMa and JMb). These juxtamembrane
ErbB4 isoforms are either susceptible or resistant to proteolytic
processing that release a soluble receptor ectodomain. Another pair
of ErbB4 isoforms differs within their cytoplasmic tails (JM-cyt1 or
JM-cyt2) [21]. Since four ErbB4 isoforms exist, we next examined
whether nucleolin can interact with the different ErbB4 isoforms.
COS7cellswereco-transfectedwithexpressionvectorsofMyc-GFP-
Nucleolin and either ErbB4-JMa-cyt1, ErbB4-JMa-cyt2, ErbB4-
JMb-cyt1 or ErbB4-JMb-cyt2. As shown in Figure 2B, all ErbB4
isoforms precipitated with nucleolin.
To determine whether nucleolin interacts with other ErbB
receptors family members we expressed each of the ErbB proteins
with or without Myc-tagged Nucleolin in COS7 cells. Lysates of
transfected cells were fractionated into supernatant and pellet and
immunoprecipitated with an anti-Myc antibody and immuno-
blotted with individual specific antibodies against ErbB1, ErbB2,
ErbB3, and ErbB4. Figure 3A demonstrates that the four ErbB
receptors were detected in immunoprecipitates from the pellet
(insoluble fraction) of cells co-expressing nucleolin and the
receptors, suggesting that all ErbB receptors associate with
nucleolin. Moreover, nuclei fractionation of transfected cells
reveals that ErbB1, either in the presence or in the absence of
nucleolin, is not detected in the nucleus (Figure 3B), indicating that
ErbB1/nucleolin interaction occurs mainly in the cell membrane.
In addition, using SKBR3 breast cancer cells that express high
levels of ErbB2 receptors we demonstrated that endogenous
Figure 1. Nucleolin binds the cytoplasmic tail of ErbB4. (A) SDS-PAGE of Coomassie blue–stained proteins isolated from PC12 cell extracts,
loaded on GST-ErbB4 agarose affinity matrix or control GST agarose matrix. The arrow indicates a specific 110-kD band, which was identified as
nucleolin by mass spectroscopy. (B) COS7 cells were transiently transfected with expression vector of Myc-Nucleolin. Cell lysates were incubated with
immobilized GST-ErbB4 or GST. Proteins retained on the beads were resolved by SDS-PAGE and then processed for Western blot using anti-Myc
antibodies. (C) Cell lysates prepared from Du145 cells were incubated with immobilized GST-ErbB4 or GST. Eluates from GST-ErbB4 and GST control
affinity matrices were resolved by SDS-PAGE and then processed for Western blot using a monoclonal mouse anti-nucleolin antibody.
doi:10.1371/journal.pone.0002310.g001
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(Figure 3C), indicating, that the interaction may occur also in
cells endogenously expressing these proteins.
Nucleolin induces ErbB receptor phosphorylation
To determine whether nucleolin affects ErbB tyrosine phosphor-
ylation we coexpressed ErbB proteins and nucleolin in COS-7 cells.
Surprisingly, when nucleolin was coexpressed with ErbB1 it induced
receptor phosphorylation even in the absence of the ligand, EGF.
This was evident using anti-phosphorylated EGFR antibodies that
recognize phosphorylated tyrosine 1068 of the EGFR (Figure 4A).
Similarly, coexpression of nucleolin and ErbB2 resulted in ErbB2
phosphorylation as detected using anti-phosphorylated ErbB2
antibodies that recognize phosphorylated tyrosine 1248 on ErbB2
(Figure 4A). To further evaluate the effect of nucleolin on ErbB
phosphorylation, lysates of transfected cells were immunoprecipitat-
ed with anti-phosphotyrosine antibody and immunoblotted with
individual specific antibodies against ErbB receptors. As control for
receptor phosphorylation, cells were stimulated with EGF (100 ng/
ml) or NRG (100 ng/ml) as indicated. The results demonstrate that
nucleolin induces receptor phosphorylation of all ErbB receptors
even the ErbB3 that has no kinase activity (Figure 4B). These results
suggest that nucleolin ErbB interaction may have functional role, as
it affects receptor phosphorylation.
Nucleolin enhances ErbB1 receptor dimerization
To address the possibility that nucleolin induces the competence
of ErbB receptor dimerization and trans-auto-phosphorylation, we
examined the effect of nucleolin on receptor dimerization. Using
covalent crosslinking experiment we demonstrated that nucleolin
induced ErbB1 dimerization in a ligand independent manner
(Figure 5). A similar phenomenon was observed when addressing
EGF-induced homodimerization of ErbB-1 as a control. These
observations may suggest that the receptor phosphorylation
induced by nucleolin may result due to nucleolin-mediated
receptor dimerization.
Nucleolin overexpression reduces receptor
disappearance and induces anchorage-independent
growth in ErbB1 overexpressing Rat-1 cells
In order to further examine the effect of nucleolin on ErbB1-
mediated responses we prepared Rat-1 cells stably transfected to
express ErbB1, nucleolin or ErbB1 and nucleolin. The expression
levels of ErbB1 or nucleolin in the selected clones is shown in
Figure 6A. Next,weexamined the effectof EGF on receptorlevelsin
the various cell lines. The Rat-1 cell lines were stimulated with EGF
(100 ng/ml)forthe indicatedtime and cellextractswere subjected to
Immunoblot analysis. As shown in Figure 6B, EGF induced a time
dependent reduction inErbB1 levelswhichwas significantly lower in
cells overexpressing nucleolin. These results indicate that nucleolin
may affect receptor levels either by reducing receptor degradation or
by increasing receptor formation. In order to assess effects of ErbB1
and nucleolin on colony formation induced by EGF, Rat-1 stable
cloneswere plated insoftagar and maintained inculturefor 14 days,
in the presence of 100 ng/ml EGF. The number and size of colonies
were then estimated from three individual clones. Results of a typical
experiment are shown in Figure 7. Rat-1 cells overexpressing either
ErbB1 or nucleolin formed relatively small colonies. However, Rat-1
Figure2.NucleolinbindstothefourErbB4isoforms.(A)COS7cellsweretransientlyco-transfectedwithexpressionvectorofErbB4andeitherMyc-
Nucleolin, or Myc-TGFbIIR. Cell lysates were subjected to immunoprecipitation with anti-Myc antibodies and immunoblotted with anti-ErbB4 antibodies,
as a control the total cell lysates were reacted with anti-ErbB4 antibodies. (B) COS7 cells were transiently co-transfected with or without expression vector
of each of the ErbB4 receptor isoforms and Myc-GFP-Nucleolin. Cell lysates were subjected to immunoprecipitation with anti-ErbB4 antibodies. The
immunoprecipitated proteins as well as total cell lysates were immunoblotted with anti-GFP antibodies or with anti Myc antibodies as indicated.
doi:10.1371/journal.pone.0002310.g002
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colonies in soft agar. Moreover, the number of the colonies was
significantly higher in ErbB1 and nucleolin overexpressing cells
compared to the ErbB1 or nucleolin overexpressing cells (p,0.001).
Pools of mock-transfected Rat-1 cells were plated in soft agar as a
control. The mock-transfected Rat-1 cells, even in the presence of
EGF, were unable to proliferate in the absence of adhesion, and
formed no colonies in soft agar (data not shown). These results
indicate that EGF enhanced the anchorage-independent growth of
the cells overexpressing both ErbB1 and nucleolin.
Discussion
We report that nucleolin associates with the cytoplasmic region
of all ErbB-4 receptor isoforms. Moreover, our findings demon-
strate that nucleolin associates also with the other ErbB family
members; ErbB1, ErbB2 and ErbB3. Overexpression of nucleolin
with ErbB proteins enhances dimerization and phosphorylation,
reduces ligand-induced receptor degradation, and enhances
ligand-induced anchorage independent growth. These results
indicate that nucleolin may associate with the ErbB receptors
and affect their activation even in a ligand independent manner.
Furthermore, based on the presented data we suggest that
nucleolin may modulate ErbB receptors activities.
The ErbB family of receptor tyrosine kinases consists of four
different proteins called EGFR/ErbB1/HER1, ErbB2/Neu/
HER2, ErbB3/HER3, and ErbB4/HER4 [22]. Under normal
physiological conditions, the ErbB receptors play crucial roles in
propagating signals regulating cell proliferation, differentiation,
motility, and apoptosis [23]. They are activated by ligand binding,
Figure 3. Nucleolin binds to the four ErbB receptors. (A) COS7 cells were transiently co-transfected with expression vector of each of the ErbB
receptors and Myc-Nucleolin. Cell lysates were separated into cytosolic (supernatant) and total membrane (pellet) fractions. The pellet fraction was
subjected to immunoprecipitation with anti-Myc (nucleolin) or anti-HA (control) antibodies and immunoblotted with specific ErbBs antibodies. Total
pellet and supernatant extracts are shown in the right lanes of each panel. (B) COS7 cells were transiently co-transfected with expression vector of
ErbB1 and Myc-Nucleolin. Nuclear and non-nuclear cell extracts were immunoblotted with anti-ErbB1 antibodies. As control for the fractionation
purity Blots were reacted with anti-PARP antibodies (as a nuclear marker) and anti-tubulin antibodies (as a cytosolic marker). (C) Cell lysates prepared
from SKBR3 cells were subjected to immunoprecipitation with either anti-nucleolin or anti ErbB2 antibodies and immunoblotted with either anti-
ErbB2 or anti-nucleolin antibodies as indicated, as a control total cell lysates are shown in the right lane of each panel.
doi:10.1371/journal.pone.0002310.g003
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phosphorylation of specific tyrosine residues. These phosphorylated
tyrosines, in turn, provide recognition sites for cytoplasmic proteins,
which link ErbB receptors to downstream signaling transduction
cascades such as the MAP kinase pathway. As overexpression of
ErbB receptors is often found in several human tumors such as
breast, lung, head, and neck [24], their precise role in the cell is of
particular biological and pharmacological importance.
Nucleolin is a major constituent of nucleoli in exponentially
growing cells [19] and functions in the organization of nucleolar
chromatin [25], packaging of pre-rRNA [26], rDNA transcription
[27], and ribosome assembly by shuttling between the nucleus and
the cytoplasm [28]. It was demonstrated that nucleolin, is a
multifunctional protein present in nucleus, cytoplasm, and on the
surface of some types of cells [17]. Although mainly characterized as
a nucleolar protein, nucleolin also functions as a cell surface receptor
where it is associated with the actin cytoskeleton and acts as a
shuttling protein between cytoplasm and nucleus [29]. Cell surface
nucleolin has been reported to bind lipoproteins, laminin, midkine,
L-selectin, lactoferrin and other growth factors [30–33]. Moreover,
nucleolin was identified as a binding partner for receptor protein
tyrosine phosphatase-sigma ectodomain in skeletal muscle [34].
Thus, the present findings of this new interaction between nucleolin
and the ErbB cell surface receptors, add another layer to the
complexity of nucleolin/ ErbB- mediated functions.
Our study demonstrates that nucleolin not only binds all ErbB
receptors family members but can also affect ErbB1, ErbB2 ErbB3
or ErbB4 phosphorylation. Among ErbB family members, ErbB1
Figure 4. Nucleolin induces ErbB phosphorylation in a ligand independent manner. (A) COS7 cells were transiently co-transfected with
expression vector of either ErbB1 or ErbB2 receptors alone or with Myc-Nucleolin. Following 30 min serum deprivation, cells were either untreated or
treated with EGF 100 ng/ml for 5 min. Cell lysates were immunoblotted with anti-phosphorylated EGFR or anti-phosphorylated ErbB2 antibodies
respectively. As control, lysates were immunoblotted with anti-EGFR or anti-ErbB2 antibodies. Note that at time 0 phosphorylated receptors are
detected in cells expressing nucleolin and EGFR or ErbB2. (B) COS7 cells were transiently co-transfected with expression vector of each of the ErbB
receptors and Myc-Nucleolin. Following 30 min serum deprivation cells were untreated or treated with either EGF 100 ng/ml or NRG 100 ng/ml for
5 min as indicated. Cell lysates were subjected to immunoprecipitation with anti-phosphotyrosine antibodies (PY20) and immunoblotted with
specific ErbB antibodies. Note that in untreated cells, phosphorylated receptor is detected in cells expressing nucleolin and ErbB receptor. The values
represent fold induction compared to the receptor levels in untreated cells (1).
doi:10.1371/journal.pone.0002310.g004
Figure 5. Nucleolin induces ErbB1 dimerization. COS7 cells were
transiently co-transfected with expression vector of ErbB1 receptors
alone or with Myc-Nucleolin. Following 30 min serum deprivation cells
were untreated or treated with EGF 100 ng/ml for 5 min. Cell lysates
were incubated with BS
3 crosslinker (2 mM) for 1 h and immunoblotted
with anti-EGFR antibodies. Note that in the presence of nucleolin
receptor dimmers appears to be similar to the level of receptor dimmers
induced by EGF in the absence of nucleolin.
doi:10.1371/journal.pone.0002310.g005
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ErbB2 does not bind any known ligand and ErbB3 has no intrinsic
kinase activity, however, ErbB3 still mediate signaling by hetero-
dimerization with other receptors of the family [22]. Our results
demonstrating the ability of nucleolin to induce ErbB3 phosphor-
ylation may be a consequence of heterodimerization with endoge-
nous ErbB1 or ErbB2 expressed in COS7 cells. Thus, overexpressed
nucleolin may affect the levels of receptor activation.
Ligand-induced receptor phosphorylation depends on receptor
dimerization [10]. However, it was also demonstrated that protein
interactions may affect receptor activities. For example, Erbin
protein binds to the c-terminal end of ErbB2 receptor and
regulates its activity [15]. Nucleolin by interacting with ErbB
proteins also affect their activities. It was reasonable to assume that
nucleolin affects receptor dimerization and thus its activation.
Indeed, using crosslinking experiments we demonstrated that
nucleolin induces ErbB1 receptor dimerization in a ligand
independent manner. This observation may suggest that nucleolin
binding to the cytoplasmic tail of the receptor may affect the ability
of the receptor to dimerize.
Similarly to ErbB proteins, nucleolin is abundant in proliferating
cancerous cells, and high levels of nucleolin expression are related to
poorclinicalprognosisforcertaintypesofcancer[35,36].Theability
of nucleolin to affect receptor dimerization and phosphorylation in a
ligand independent manner may partially explain the constitutive
activation of ErbB proteins in specific tumors [37–39]. In our study
we demonstrated that EGF stimulation induced reduction in
receptor levels in the mock or ErbB1 expressing cells and slower
receptor disappearance in nucleolin expressing cells. In addition,
anchorage independent growth in cells expressing nucleolin and
ErbB1 was significantly higher compared to cells expressing each of
these proteins alone. These may result from extended EGFR
signaling in nucleolin expressing cells. Currently we do not know
whether the effect of nucleolin on receptor levels results from
changes in receptor internalization, degradation or synthesis.
In conclusion, our studies provide the first evidence for the
connection between nucleolin and ErbB receptors. These results
suggest that nucleolin not only interacts with ErbB proteins but
may also affect their activation. It may also provide a new insight
into the mechanism by which overexpressed ErbB receptors
mediate cell transformation in a ligand independent manner.
Nucleolin is mainly expressed in the nucleus. ErbB receptors are
mainly expressed in the cell membrane. Interestingly, nuclear
localization of EGFR was previously demonstrated and a direct
role of EGFR as transcription factor was suggested (reviewed in
[40]). Other ErbB family members were also found in the nucleus;
ErbB2/HER2 [41], ErbB4/HER4 [42] and ErbB3/HER3 [43].
Nucleolin may conceivably function as a shuttle protein directing
ErbB receptors into the nucleus. Our results indicate that the
initial interaction is in the cell membrane, however, further studies
are needed to explore the exact localization of these proteins
following ligand stimulation and the mechanism by which
nucleolin affects ErbB activation and ErbB-mediated responses.
Materials and Methods
Materials and Buffers
Human recombinant NRGb was purchased from R&D System
Inc. (Oxon, UK). EGF (human recombinant) was purchased from
Boehringer Mannheim. Polyclonal rabbit anti- ErbB1, ErbB2,
ErbB3, ErbB4 antibodies, monoclonal mouse anti-phosphotyrosine
(PY20), mouse anti-GFP (B-2) and mouse anti-nucleolin (C23) were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Polyclonal rabbit anti phosphorylated ErbB1 (Tyr1068) and
phosphorylated ErbB2 (Tyr1248) were purchased from Cell
Signaling technology. Monclonal mouse anti-PARP antibodies were
from BIOMOL International, LP. Monoclonal mouse anti c-Myc
(9E10) and monoclonal anti HA (12C5a)w a sd o n a t e db yD r .
Altchuler Yoram the Hebrew University, Israel. All other reagents
were from Sigma. HNTG buffer contained 20 mM HEPES
(pH 7.5), 150 mM NaCl, 0.1% Triton X-100 and 10% glycerol.
Solubilization buffer contained 50 mM HEPES (pH 7.5), 150 mM
NaCl, 1% Triton X-100, 1 mM EGTA, 1 mM EDTA, 1.5 mM
MgCl2, 10% glycerol, 2 mM sodium vanadate, 1 mMp h e n y l -
Figure 6. Nucleolin reduces ErbB1 disappearance. (A) Total cell lysates of Rat-1 cells stably expressing ErbB1, nucleolin or ErbB1 and nucleolin
were immonoblotted with anti-Myc to recognize Myc-Nucleolin or anti-GFP to identify GFP-ErbB1. (B) Rat-1 cells stably expressing empty vector,
ErbB1, nucleolin or ErbB1 and nucleolin were grown in 6 wells plates (10
6 cells/well). Cells were deprived of serum for 24 h then treated with EGF
100 ng/ml for the indicated time periods. Total cell lysates were analyzed by Western blot, using anti-ErbB1 antibodies. As control total cell lysate was
immunoblotted with anti-tubulin antibodies. Note that in the presence of nucleolin the EGFR is more stabilized following EGF stimulation.
doi:10.1371/journal.pone.0002310.g006
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tin. Pull Down buffer contained 50 mM TRIS-HCl (pH 7.6),
20 mM MgCl2, 150 mM NaCl, 1 mM DTT, 2 mM sodium
vanadate, 1 mM phenylmethylsulfonylfluoride, 10 mg/ml aprotanin,
10 mg/ml leupeptin, 0.5% NP40, 5 mg/ml pepstatine and 1 mM
Benzamidine. Binding buffer contained 50 mM TRIS-HCl
(pH 7.6), 10 mM MgCl2, 100 mM NaCl, 0.5 mM DTT and
0.5 mg/ml BSA.
Cell lines
COS-7, SKBR3 and Rat-1 cell lines were grown in Dulbecco’s
modified Eagle’s (DMEM) supplemented with 10% fetal bovine
serum. PC12-ErbB4 cell line [44] was grown in Dulbecco’s
modified Eagle’s supplemented with 10% fetal bovine serum and
10% horse serum. DU145 cell line was grown in RPMI 1640
supplemented with 10% fetal bovine serum. For transient
expression cells were transfected using jetPEI (Poly plus transfec-
tion, USA). Cell lysates were prepared 48 h following transfection
as described. The Rat-1 fibroblast cells were used for stably
expressing the ErbB-1 receptor and nucleolin. Expression vector
pEGFP-ErbB-1 containing the coding region of ErbB-1 and
expression vector pCDNA3-Myc-Nucleolin containing the coding
region of nucleolin [45] were introduced by CaPO4 transfection
into Rat-1 cells either alone or together. The neomycin (G418)
resistant colonies were checked for ErbB-1 or nucleolin expression
and several colonies were selected for further analysis.
Figure 7. Nucleolin and ErbB1- induced anchorage-independent growth. (A) Rat-1 cells stably expressing empty vector (not shown), ErbB1,
nucleolin or ErbB1 and nucleolin were seeded in soft agar (6000 cells/well in 96 well plates) in medium containing 10% FBS, 0.3% agar, in the
presence of 100 ng/ml EGF. The extent colony formation was determined 2 weeks later. Cells were dyed with MTT and the wells were photographed
and colonies were counted. (B) Results were quantified using image analyzer program Image pro-Plus. The results are presented as total number of
colonies and size of colonies. Note that nucleolin+ErbB1 but not each protein alone induced more and larger colonies. Results are the mean6SD 6
determinations. Each experiment was repeated at least three times with 3 different clones, with similar results.
doi:10.1371/journal.pone.0002310.g007
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The ErbB4 cytoplasmic tail was amplified using the following
primers: 59 TAGACCCGGGAGAAGGAAGAGCATC and 59
TCGCCCGGGTTATGACACCACAGTATTCCG. The ampli-
fied fragment was digested with XmaI and cloned into pGEX-3X
expression vector.
AC 9 terminally Myc-tagged mouse nucleolin (pMT21-Myc-
Nucleolin) was generously provided by Dr. Bacharach E. (Tel-Aviv
University, Israel). Myc -Nucleolin cDNA was amplified using the
following primers: 59 CCGGAATTCGCCACCATGGTGAAG-
CTCGCG and 59 CGAACCATGATGGCTCGAATCAC. The
amplified fragment was digested with EcoRI and XbaI and cloned
into pcDNA3 expression vector. In order to generate GFP-fused
Nucleolin-Myc expression vector, the pcDNA3-Nucleolin-Myc
vector was digested with EcoRI and ApaI and cloned into
pEGFP-C2 expression vector. ErbB1-GFP (pEGFP-N2) was
generously provided by Dr. Erlich M (Tel-Aviv University, Israel).
Lysate Preparation, Cell fractionation,
Immunoprecipitation and Immunoblotting
Cells were exposed to the indicated stimuli. After treatment,
cells were solubilized in lysis buffer. Lysates were cleared by
centrifugation. For direct electrophoretic analysis, boiling gel
sample buffer was added to cell lysates. For cell fractionation two
methods were used. First, cells were homogenized, and the
supernatant (soluble proteins) and the pellet (insoluble proteins)
fractions were obtained by centrifugation (100,0006g, 30 min,
4uC) [46]. Samples of the pellet fractions were subjected to
immunoprecipitation. Second we separated nuclei from the other
cell fractions as described previously [47]. Briefly, cells were
washed twice with ice-cold phosphate-buffered saline, harvested
by scraping with a rubber policeman, and lysed in a lysis buffer
(20 mM HEPES, pH 7.0, 10 mM KCl, 2 mM MgCl2, 0.5%
Nonidet P-40, 1 mM Na3VO4, 10 mM NaF, 1 mM phenyl-
methanesulfonyl fluoride, 2 mg/ml aprotinin). After incubation on
ice for 10 min, the cells were homogenized by 20 strokes in a
tightly fitting Dounce homogenizer. The homogenate was
centrifuged at 1,5006g for 5 min to sediment the nuclei. The
supernatant was then centrifuged at a maximum speed of
16,1006g for 20 min, and the resulting supernatant formed the
non-nuclear fraction. The nuclear pellet was washed three times
with lysis buffer to remove any contamination from cytoplasmic
membranes. To extract nuclear proteins, the isolated nuclei were
resuspended in NETN buffer (150 mM NaCl, 1 mM EDTA,
20 mM Tris-Cl, pH 8.0, 0.5% Nonidet P-40, 1 mM Na3VO4,
10 mM NaF, 1 mM phenylmethanesulfonyl fluoride, and 2 mg/ml
aprotinin), and the mixture was sonicated briefly to aid nuclear
lysis. Nuclear lysates were collected after centrifugation at
16,1006g for 20 min at 4uC.
For immunoprecipitation, antibodies were first coupled to anti-
mouse IgG agarose (for monoclonal antibodies) or protein A-
sepharose (for polyclonal antibodies) for 1 h at RT. Then the
proteins in the lysate supernatant were immunoprecipitated with
aliquots of the beads-antibody complexes for 2 h at 4uC. The
immunoprecipitates were washed three times with HNTG,
resolved by SDS-polyacrylamide gel electrophoresis (PAGE)
through 7.5% gels and electrophoretically transferred to nitrocel-
lulose membrane. Membranes were blocked for 1 h in TBST
buffer (0.02 M Tris-HCl pH 7.5, 0.15 M NaCl, and 0.05%
Tween 20) containing 6% milk, blotted with 1 mg/ml primary
antibodies for 2 h, followed by 0.5 mg/ml secondary antibody
linked to horseradish peroxidase. Immunoreactive bands were
detected with the enhanced chemiluminescence reagent (Amer-
sham Corp, Buckinghamshire, UK).
Cross-linking
Cross-linking experiments were performed by addition of 2 mM
bis(sulfosuccinimidyl)suberate(BS
3),tothelysisbufferfor20 minon
ice. The chemical crosslinking reaction was stopped by adding
50 mM Glycine and the samples were resolved by SDS-PAGE [48].
Soft Agar Assay
Cells were seeded at a density of 6000 cells/well in 96 well plates
in DMEM containing 10% FBS. The cells were mixed with
0.05 ml (per each well) of 0.33% noble agar, and the mixture was
poured onto a layer of 0.05 ml 1% noble agar in DMEM
containing 10% FBS. The upper layer of the agar was covered
with 0.1 ml of medium. The agar layers contained either PBS
(control) or 100 ng/ml EGF. Assays were performed in at least six
repeats. The number and sizes of the colonies were estimated on
day 14, using a binocular and a light microscope with the image
analyzer program Image pro-Plus.
GST Pull-Down Assay
To characterize proteins that interact with the cytoplasmic tail
of ErbB4, a GST-ErbB4 column was generated by absorbing
20 ml of GST-ErbB4 -producing E.coli lysate (resulting from a 1-
liter culture) to 1 ml of glutathione-Sepharose (Sigma). A similar
column was prepared from GST-producing E. coli. PC12 cell
lysate was prepared and a total of 2 mg protein was loaded on
GST or GST-ErbB4 columns (in the presence of 0.5 ml binding
buffer) for 2 h at 4uC. After the incubation the beads were washed
three times with binding buffer. The GST and GST-ErbB4 bound
proteins were eluted in boiling sample buffer and resolved by SDS-
PAGE through 7.5% gels and either electrophoretically trans-
ferred to nitrocellulose membrane, or protein bands on the gel
were visualized by Coomassie Blue staining. In the latter case,
bands uniquely bound to GST-ErbB4 were further analyzed by
Mass Spectrometry using API QSTAR
TM Pulsar Hybrid LC/
MS/MS System.
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